GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » COGS-to-Revenue

Pulsion Medical Systems SE (LTS:0NFX) COGS-to-Revenue : 0.65 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE COGS-to-Revenue?

Pulsion Medical Systems SE's Cost of Goods Sold for the six months ended in Dec. 2023 was €23.39 Mil. Its Revenue for the six months ended in Dec. 2023 was €35.80 Mil.

Pulsion Medical Systems SE's COGS to Revenue for the six months ended in Dec. 2023 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pulsion Medical Systems SE's Gross Margin % for the six months ended in Dec. 2023 was 34.64%.


Pulsion Medical Systems SE COGS-to-Revenue Historical Data

The historical data trend for Pulsion Medical Systems SE's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE COGS-to-Revenue Chart

Pulsion Medical Systems SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.41 0.47 0.48 0.65

Pulsion Medical Systems SE Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.41 0.47 0.48 0.65

Pulsion Medical Systems SE COGS-to-Revenue Calculation

Pulsion Medical Systems SE's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=23.394 / 35.795
=0.65

Pulsion Medical Systems SE's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=23.394 / 35.795
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulsion Medical Systems SE  (LTS:0NFX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pulsion Medical Systems SE's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 23.394 / 35.795
=34.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Pulsion Medical Systems SE COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulsion Medical Systems SE Business Description

Traded in Other Exchanges
N/A
Address
Hans-Riedl-Street 17, Feldkirchen, DEU, 85622
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE Headlines

No Headlines